Skip to content

APOTHEEK ORSCAMP: what changed

BE 0430.106.908NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€26,023
2024 · €40,388-€14,365
Equity
€373,402
2024 · €394,005-€20,603
Cash
€113,646
2024 · €131,724-€18,079
Balance sheet total
€623,563
2024 · €716,923-€93,361

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€43,808

    down €43,808 (-48.7%), from €89,881 to €46,073

    of which Trade receivables: -€44,218

  • Tangible fixed assets -€24,048

    down €24,048 (-8.1%), from €298,286 to €274,238

    of which Land and buildings: -€20,769

  • Cash -€18,079

    down €18,079 (-13.7%), from €131,724 to €113,646

    mainly Debts after one year (-€54,907) and Contributions, distributions and other (-€46,627)

Equity and liabilities
  • Debts after one year -€54,907

    down €54,907 (-39.0%), from €140,888 to €85,981

  • Trade debts -€32,156

    down €32,156 (-67.5%), from €47,609 to €15,453

  • Reserves -€20,603

    down €20,603 (-6.2%), from €332,005 to €311,402

    of which Distributable reserves: -€20,603

  • Tax, wage and social debts +€11,479

    up €11,479 (+235%), from €4,882 to €16,360

    of which Taxes: +€10,305

Income statement
  • Gross operating margin -€12,748

    down €12,748 (-13.1%), from €97,256 to €84,508

  • Taxes -€4,805

    down €4,805 (-29.8%), from €16,144 to €11,339

  • Staff costs +€4,441

    up €4,441 (+66.6%), from €6,671 to €11,112

  • Financial charges +€2,065

    up €2,065 (+27.9%), from €7,404 to €9,469

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €40,388
Gross operating margin -€12,748
Staff costs -€4,441
Depreciation +€482
Other operating charges -€33
Financial income -€365
Financial charges -€2,065
Taxes +€4,805
Result 2025 €26,023
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€83,454
Investment €0
Financing -€101,533
Cash 2024 €131,724
Net result for the year +€26,023
Depreciation +€24,048
Stocks and contracts +€6,976
Receivables within one year +€43,808
Deferred charges and accrued income +€450
Trade debts -€32,156
Tax, wage and social debts +€11,479
Other debts +€3,056
Accrued charges and deferred income -€230
Debts after one year -€54,907
Contributions, distributions and other -€46,627
Cash 2025 €113,646
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €716,923 €623,563 -€93,361 -13.0%
Fixed assets 21/28 €298,286 €274,238 -€24,048 -8.1%
Tangible fixed assets 22/27 €298,286 €274,238 -€24,048 -8.1%
Land and buildings 22 €292,343 €271,574 -€20,769 -7.1%
Plant, machinery and equipment 23 €5,943 €2,664 -€3,279 -55.2%
Current assets 29/58 €418,637 €349,324 -€69,313 -16.6%
Amounts receivable after more than one year 29 €15,000 €15,000 = 0.0%
Other amounts receivable 291 €15,000 €15,000 = 0.0%
Stocks and contracts in progress 3 €178,413 €171,437 -€6,976 -3.9%
Stocks 30/36 €178,413 €171,437 -€6,976 -3.9%
Amounts receivable within one year 40/41 €89,881 €46,073 -€43,808 -48.7%
Trade receivables 40 €85,953 €41,735 -€44,218 -51.4%
Other amounts receivable 41 €3,928 €4,338 +€410 +10.4%
Cash at bank and in hand 54/58 €131,724 €113,646 -€18,079 -13.7%
Deferred charges and accrued income 490/1 €3,618 €3,169 -€450 -12.4%
Total equity and liabilities 10/49 €716,923 €623,563 -€93,361 -13.0%
Equity 10/15 €394,005 €373,402 -€20,603 -5.2%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €332,005 €311,402 -€20,603 -6.2%
Non-distributable reserves 130/1 €19,970 €19,970 = 0.0%
Legal reserve 130 €19,970 €19,970 = 0.0%
Distributable reserves 133 €312,035 €291,432 -€20,603 -6.6%
Amounts payable 17/49 €322,918 €250,161 -€72,758 -22.5%
Amounts payable after more than one year 17 €140,888 €85,981 -€54,907 -39.0%
Financial debts 170/4 €140,888 €85,981 -€54,907 -39.0%
Amounts payable within one year 42/48 €177,686 €160,065 -€17,621 -9.9%
Current portion of amounts payable after more than one year 42 €21,057 €21,057 = 0.0%
Trade debts 44 €47,609 €15,453 -€32,156 -67.5%
Suppliers 440/4 €47,609 €15,453 -€32,156 -67.5%
Taxes, remuneration and social security 45 €4,882 €16,360 +€11,479 +235%
Taxes 450/3 €4,131 €14,436 +€10,305 +249%
Remuneration and social security 454/9 €750 €1,924 +€1,174 +156%
Other amounts payable 47/48 €104,138 €107,195 +€3,056 +2.9%
Accrued charges and deferred income 492/3 €4,345 €4,115 -€230 -5.3%
Remuneration, social security and pensions 62 €6,671 €11,112 +€4,441 +66.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €24,530 €24,048 -€482 -2.0%
Other operating charges 640/8 €3,370 €3,403 +€33 +1.0%
Gross operating margin 9900 €97,256 €84,508 -€12,748 -13.1%
Operating profit (loss) 9901 €62,685 €45,945 -€16,740 -26.7%
Financial income 75/76B €1,252 €887 -€365 -29.1%
Recurring financial income 75 €1,252 €887 -€365 -29.1%
Financial charges 65/66B €7,404 €9,469 +€2,065 +27.9%
Recurring financial charges 65 €7,404 €9,469 +€2,065 +27.9%
Profit (loss) for the period before taxes 9903 €56,533 €37,363 -€19,170 -33.9%
Income taxes 67/77 €16,144 €11,339 -€4,805 -29.8%
Profit (loss) for the period 9904 €40,388 €26,023 -€14,365 -35.6%
Profit (loss) for the period to be appropriated 9905 €40,388 €26,023 -€14,365 -35.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€324,776 to €380,006

Midpoint €347,788 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €373,402
Capitalised earnings €276,150 to €386,610
Indication €324,776 to €380,006

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€373,402
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€373,402

Capitalised earnings

net result for the year (9904)
2025
€26,023
2024
€40,388
2023
€49,570
2022
€67,495
2021
€33,663
Average result
€38,661
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€276,150 / €322,175 / €386,610

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.